Why we like health-care stocks in 2024 despite their spotty record in presidential election years
Critical rhetoric and policy uncertainty tend to weigh on health-care stocks in presidential election years. But we like many in the industry this year.

This picture shows an unit dedicated to the production of insulin pens at the factory of the US pharmaceutical company Eli Lilly in Fegersheim, eastern France.
Frederick Florin | AFP | Getty Images
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that's been true. But, there's reason to believe this year that many health-related stocks, led by Eli Lilly, could defy historical convention.